304 related articles for article (PubMed ID: 25544758)
1. Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance.
Zhitomirsky B; Assaraf YG
Oncotarget; 2015 Jan; 6(2):1143-56. PubMed ID: 25544758
[TBL] [Abstract][Full Text] [Related]
2. Lysosomes as mediators of drug resistance in cancer.
Zhitomirsky B; Assaraf YG
Drug Resist Updat; 2016 Jan; 24():23-33. PubMed ID: 26830313
[TBL] [Abstract][Full Text] [Related]
3. The role of endolysosomal trafficking in anticancer drug resistance.
Hussein NA; Malla S; Pasternak MA; Terrero D; Brown NG; Ashby CR; Assaraf YG; Chen ZS; Tiwari AK
Drug Resist Updat; 2021 Jul; 57():100769. PubMed ID: 34217999
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal sequestration of weak base drugs, lysosomal biogenesis, and cell cycle alteration.
Mlejnek P; Havlasek J; Pastvova N; Dolezel P; Dostalova K
Biomed Pharmacother; 2022 Sep; 153():113328. PubMed ID: 35785701
[TBL] [Abstract][Full Text] [Related]
5. Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis.
Zhitomirsky B; Assaraf YG
Oncotarget; 2017 Jul; 8(28):45117-45132. PubMed ID: 28187461
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal Fusion: An Efficient Mechanism Increasing Their Sequestration Capacity for Weak Base Drugs without Apparent Lysosomal Biogenesis.
Skoupa N; Dolezel P; Mlejnek P
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947839
[TBL] [Abstract][Full Text] [Related]
7. Overcoming multidrug resistance via photodestruction of ABCG2-rich extracellular vesicles sequestering photosensitive chemotherapeutics.
Goler-Baron V; Assaraf YG
PLoS One; 2012; 7(4):e35487. PubMed ID: 22530032
[TBL] [Abstract][Full Text] [Related]
8. Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity.
Zhitomirsky B; Yunaev A; Kreiserman R; Kaplan A; Stark M; Assaraf YG
Cell Death Dis; 2018 Dec; 9(12):1191. PubMed ID: 30546014
[TBL] [Abstract][Full Text] [Related]
9. Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones.
Al-Akra L; Bae DH; Sahni S; Huang MLH; Park KC; Lane DJR; Jansson PJ; Richardson DR
J Biol Chem; 2018 Mar; 293(10):3562-3587. PubMed ID: 29305422
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration.
Yamagishi T; Sahni S; Sharp DM; Arvind A; Jansson PJ; Richardson DR
J Biol Chem; 2013 Nov; 288(44):31761-71. PubMed ID: 24062304
[TBL] [Abstract][Full Text] [Related]
11. Nuclear miR-30b-5p suppresses TFEB-mediated lysosomal biogenesis and autophagy.
Guo H; Pu M; Tai Y; Chen Y; Lu H; Qiao J; Wang G; Chen J; Qi X; Huang R; Tao Z; Ren J
Cell Death Differ; 2021 Jan; 28(1):320-336. PubMed ID: 32764647
[TBL] [Abstract][Full Text] [Related]
12. Impaired TFEB-mediated lysosomal biogenesis promotes the development of pancreatitis in mice and is associated with human pancreatitis.
Wang S; Ni HM; Chao X; Wang H; Bridges B; Kumer S; Schmitt T; Mareninova O; Gukovskaya A; De Lisle RC; Ballabio A; Pacher P; Ding WX
Autophagy; 2019 Nov; 15(11):1954-1969. PubMed ID: 30894069
[TBL] [Abstract][Full Text] [Related]
13. Monitoring TFEB translocation.
Chen G; Mu C; Chen Y; An N; Zhu Y; Kepp O; Kroemer G
Methods Cell Biol; 2021; 164():1-9. PubMed ID: 34225908
[TBL] [Abstract][Full Text] [Related]
14. Sub-lethal oxidative stress induces lysosome biogenesis via a lysosomal membrane permeabilization-cathepsin-caspase 3-transcription factor EB-dependent pathway.
Leow SM; Chua SX; Venkatachalam G; Shen L; Luo L; Clement MV
Oncotarget; 2017 Mar; 8(10):16170-16189. PubMed ID: 28002813
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome profiling analysis reveals that ATP6V0E2 is involved in the lysosomal activation by anlotinib.
Sun X; Shu Y; Yan P; Huang H; Gao R; Xu M; Lu L; Tian J; Huang D; Zhang J
Cell Death Dis; 2020 Aug; 11(8):702. PubMed ID: 32839434
[TBL] [Abstract][Full Text] [Related]
16. Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers.
Adar Y; Stark M; Bram EE; Nowak-Sliwinska P; van den Bergh H; Szewczyk G; Sarna T; Skladanowski A; Griffioen AW; Assaraf YG
Cell Death Dis; 2012 Apr; 3(4):e293. PubMed ID: 22476101
[TBL] [Abstract][Full Text] [Related]
17. Enhanced lysosomal function is critical for paclitaxel resistance in cancer cells: reversed by artesunate.
Li Z; Zhu YT; Xiang M; Qiu JL; Luo SQ; Lin F
Acta Pharmacol Sin; 2021 Apr; 42(4):624-632. PubMed ID: 32704040
[TBL] [Abstract][Full Text] [Related]
18. Enhancing lysosomal biogenesis and autophagic flux by activating the transcription factor EB protects against cadmium-induced neurotoxicity.
Pi H; Li M; Tian L; Yang Z; Yu Z; Zhou Z
Sci Rep; 2017 Feb; 7():43466. PubMed ID: 28240313
[TBL] [Abstract][Full Text] [Related]
19. Oblongifolin C suppresses lysosomal function independently of TFEB nuclear translocation.
Wu M; Lao YZ; Tan HS; Lu G; Ren Y; Zheng ZQ; Yi J; Fu WW; Shen HM; Xu HX
Acta Pharmacol Sin; 2019 Jul; 40(7):929-937. PubMed ID: 30333555
[TBL] [Abstract][Full Text] [Related]
20. Sunitinib treatment promotes metastasis of drug-resistant renal cell carcinoma via TFE3 signaling pathway.
Li L; Zhao S; Liu Z; Zhang N; Pang S; Liu J; Liu C; Fan Y
Cell Death Dis; 2021 Feb; 12(2):220. PubMed ID: 33637706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
